Amphastar unit gets FDA warning letter over manufacturing violations
Seeking Alpha ·
Amphastar Pharmaceuticals ( AMPH ) traded lower in the premarket on Wednesday after the company disclosed that one of its subsidiaries received a warning letter from the U.S. FDA regarding manufacturing-related violations in a facility in California. International Medication Systems, Limited, a subsidiary of
DYAX Investor Sentiment
Bullish (Long) 63% · Bearish (Short) 37%
454 participants
Related News
- Industrials stocks with perfect A+ EPS revision grades ahead of Q2 results
- Nvidia reiterated Buy at BofA, firm sees 'compelling value multiple'
- Dollar Tree earns upgrades at Raymond James, Goldman Sachs
- Amazon's Moonraker project to enhance Alexa+ proves pricey: report
- Tech insiders are buying like never before
- Enerpac Tool to buy Gladstone’s SFE Group in $472M deal